Kraig Biocraft Laboratories Inc (KBLB)

[rayovac812]

This PR did not break significant new ground. No argument there.

Maybe it isn't fair of me to criticize at this point, but this definitely falls under the "alternative deal structure." On the surface it looks like it is a simple joint venture as stated by some. But it is actually more, of which I am sure I don't understand completely.

What it does do is streamline management of the company. It probably initiates tax breaks, keeps KBLB leaner, opens or keeps the books open to KBLB and other advantages, and more.

What it isn't, is a typical joint venture deal that most other companies sign onto, where they remain more independent. This is a company built around the Spydasilk brand AND in and for Southeast Asian countries. Maybe it gets spelled out for us better in the future. I like the joint venture and the fact that a company was born around the relationship.